Base period - professional repository services for NCI, CCR's, surgery branch (SB) - 04/01/2023 thru 03/31/2024
Active Awarded Last action
- Contract number
- 75N91023F00002
- Awardee
-
Fisher Bioservices Inc. UEI LB4PCGLSJ9E6 Part of Thermo Electron Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,421,172
Award facts
- Contract value 79% obligated
-
- $1,421,171.96 Current, with exercised options
- $1,794,060.40 Potential, with all options
- Completion date 72% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- S215 Housekeeping- Warehousing/Storage
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $365,216 | |
| Exercise an Option | $358,623 | |
| Exercise an Option | $351,899 | |
| Original award | $345,434 |
About this award
Fisher Bioservices Inc., a Clinical Trials Division subsidiary of Thermo Electron Corporation, was awarded a delivery order contract by the National Cancer Institute (NCI) on April 1, 2023, to provide professional repository services for the Surgery Branch. The contract covers registration, storage, and distribution of chemicals and drugs for preclinical discovery and evaluation activities, with a ceiling value of $1.79 million. The base period runs from April 1, 2023, through March 31, 2024, with three option periods extending through March 31, 2028. Services will be performed at the contractor's facility in Rockville, Maryland. No small business set-aside designation was used for this award, which was structured as a firm fixed-price delivery order.
Fisher Bioservices brings extensive experience in biorepository and scientific services to this engagement, having served as a federal contractor since 2001 with a demonstrated track record supporting NIH agencies including the National Cancer Institute. The company's core competency in managing specialized repository services—including biospecimen storage, maintenance, and distribution—aligns directly with NCI's preclinical research infrastructure needs. This contract represents a continuation of the contractor's ongoing support for the institute's research operations, leveraging its established capabilities in chemical and pharmaceutical compound management for the federal research community.
Quick answers
Who was awarded contract 75N91023F00002?
75N91023F00002 was awarded to Fisher Bioservices Inc. by National Cancer Institute (National Institutes of Health) on April 1, 2023.
How much is contract 75N91023F00002 worth?
The government has obligated $1,421,172 on 75N91023F00002. Its potential value, with all options, is $1,794,060.
Is contract 75N91023F00002 an order under another contract?
Yes. 75N91023F00002 is a delivery order under 75N91023D00002, an indefinite delivery contract.
Was contract 75N91023F00002 competed?
The extent of competition for 75N91023F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award